RETRACTED: A New Plasma-Adapted Hydroxyethyl Starch Preparation: In Vitro Coagulation Studies (Retracted article. See vol. 25, pg. 756, 2011)

Objective: Preparing hydroxyethyl starch (HES) in a plasma-adapted solution is supposed to improve safety with regard to coagulation. The influence of a new plasma-adapted HES preparation on coagulation was studied. Design: Operator-blinded, randomized study. Setting: Laboratory in vitro study. Participants: Fifteen healthy young men scheduled for blood donation. Interventions: Blood was diluted by 10%, 30%, and 50% using either a plasma-adapted or nonplasma-adapted (prepared in saline solution) potato-derived 6% HES 130/0.42. Only the composition of the solvent of the 2 HES preparations was different. Measurements and Main Results: Rotation thromboelastometry (ROTEM; Pentapharm, Munich, Germany) was used to assess changes in coagulation; whole blood aggregometry with 3 inducers was used to assess effects of dilution with HES on platelet function. Clotting time (CT) and clot formation time were significantly prolonged by 30% and 50% dilution, showing significantly longer times in the non plasma-adapted than in the plasma-adapted HES group leg, intrinsic CT at the 30% dilution level: plasma-adapted HES 228 +/- 26 seconds [within normal range] v269 +/- 29 seconds in the nonplasma-adapted HES group). Clot strengthening and clot firmness were significantly reduced by the non plasma-adapted HES at the 30% dilution level. Platelet aggregation was significantly more reduced by the non plasma-adapted HES at the 30% and 50% dilution levels. Conclusions: Dilution with the nonplasma-adapted HES 130/0.42 was associated with more negative effects on thromboelastometry and platelet aggregation than the same HES 130/0.4 dissolved in a plasma-adapted solution. The benefits of using a plasma-adapted modern HES preparation on blood loss and use of blood/blood products in cardiac surgery need to be studied. (C) 2010 Elsevier Inc. All rights reserved.